# Study of rBet v1 Tablets

> **NCT00901914** · PHASE2 · COMPLETED · sponsor: **Stallergenes Greer** · enrollment: 483 (actual)

## Conditions studied

- Birch Pollen-related Rhinoconjunctivitis
- Rhinitis, Allergic, Seasonal

## Interventions

- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** rBet v 1
- **BIOLOGICAL:** rBet v 1
- **BIOLOGICAL:** rBet v 1

## Key facts

- **NCT ID:** NCT00901914
- **Lead sponsor:** Stallergenes Greer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-08
- **Target enrollment:** 483 (ACTUAL)
- **Last updated:** 2013-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00901914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00901914, "Study of rBet v1 Tablets". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00901914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*